News for 'Viral Research'

India logs 11,919 fresh Covid cases, 470 more deaths

India logs 11,919 fresh Covid cases, 470 more deaths

Rediff.com18 Nov 2021

The daily rise in the number of coronavirus cases has been below 20,000 for 41 straight days now and less than 50,000 fresh cases have been reported for 144 consecutive days.

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

India logs 2,075 new Covid infections, 71 deaths; active cases drop

India logs 2,075 new Covid infections, 71 deaths; active cases drop

Rediff.com19 Mar 2022

The death toll due to the viral disease climbed to 5,16,352 with 71 fresh fatalities, the data updated at 8 am stated.

Explained: What is monkeypox?

Explained: What is monkeypox?

Rediff.com20 May 2022

Monkeypox is a rare zoonotic disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the family Poxviridae, which also includes the viruses causing smallpox and cowpox disease

With 14,256 fresh cases, India's COVID-19 tally climbs to 1,06,39,684

With 14,256 fresh cases, India's COVID-19 tally climbs to 1,06,39,684

Rediff.com23 Jan 2021

The COVID-19 case fatality rate stood at 1.44 per cent.

Molnupiravir not to be included in Covid treatment now

Molnupiravir not to be included in Covid treatment now

Rediff.com11 Jan 2022

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.

India records 1,259 fresh Covid cases, 35 more deaths

India records 1,259 fresh Covid cases, 35 more deaths

Rediff.com29 Mar 2022

The number of people who have recuperated from the disease has gone up to 4,24,85,534.

India logs 22,270 fresh COVID-19 cases, 325 deaths

India logs 22,270 fresh COVID-19 cases, 325 deaths

Rediff.com19 Feb 2022

The daily positivity rate was recorded at 1.80 per cent, while the weekly positivity rate was recorded at 2.50 per cent, the ministry said.

India's active Covid cases drop below 5 lakh after 37 days

India's active Covid cases drop below 5 lakh after 37 days

Rediff.com14 Feb 2022

Daily COVID-19 cases have remained below 1 lakh for eight consecutive days now.

India's daily Covid tally falls below 20,000 mark after 201 days

India's daily Covid tally falls below 20,000 mark after 201 days

Rediff.com28 Sep 2021

The number of active cases has declined to 2,92,206, accounting for 0.87 per cent of the total number of cases -- the lowest since March 2020 -- while the national COVID-19 recovery rate was recorded at 97.81 per cent, the highest since March last year, the ministry said.

Kids can have Covid antibodies, virus in their system simultaneously

Kids can have Covid antibodies, virus in their system simultaneously

Rediff.com3 Sep 2020

Neutralising antibodies are important in potentially protecting a person from re-infection of the same virus.

Sensex, Nifty edge down on profit-booking in banking, metal stocks

Sensex, Nifty edge down on profit-booking in banking, metal stocks

Rediff.com29 Dec 2021

Benchmark indices Sensex and Nifty retreated from over one-week highs to close lower on Wednesday due to profit booking in banking, IT and metal stocks amid weak global trends. After a two-day rally, the 30-share BSE Sensex dropped by 90.99 points or 0.16 per cent to settle at 57,806.49 in volatile trade. As many as 19 of its constituents declined while 11 advanced. The broader Nifty slipped by 19.65 points or 0.11 per cent to close at 17,213.60 with 31 of its stocks ending in the red.

India records 17,921 new COVID-19 cases, 133 deaths

India records 17,921 new COVID-19 cases, 133 deaths

Rediff.com10 Mar 2021

India's COVID-19 tally rose to 1,12,62,707 with 17,921 fresh cases being reported in a day, while the recoveries surpassed 1.09 crore, the Union Health Ministry said on Wednesday.

Govt dismisses media reports on 'undercounting' of Covid deaths

Govt dismisses media reports on 'undercounting' of Covid deaths

Rediff.com17 Feb 2022

The ministry said the country has a robust system of reporting deaths, including those caused by COVID-19, and the data is compiled regularly at different levels of governance, starting from the gram panchayat level to the district level and the state level.

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you

Rediff.com13 Apr 2021

The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:

Scientists identify 6 potential drugs for COVID-19

Scientists identify 6 potential drugs for COVID-19

Rediff.com10 Apr 2020

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

Beware! Zika reaches India, WHO confirms 3 cases in Gujarat

Beware! Zika reaches India, WHO confirms 3 cases in Gujarat

Rediff.com28 May 2017

Those infected with the virus may have mild fever, skin rashes, conjunctivitis, muscle and joint pain or headache.

Booster jab should protect current, future Covid strains: Randeep Guleria

Booster jab should protect current, future Covid strains: Randeep Guleria

Rediff.com23 Mar 2023

The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.

New Covid strains may lead to spike in hospitalisation, fear experts

New Covid strains may lead to spike in hospitalisation, fear experts

Rediff.com27 Oct 2022

An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.

Monsoon: 10 Foods To Stay Healthy

Monsoon: 10 Foods To Stay Healthy

Rediff.com14 Jul 2022

A pinch of turmeric in a glass of milk or with honey in hot water would be ideal for the monsoon.

What India needs to do to avert China-like Covid surge

What India needs to do to avert China-like Covid surge

Rediff.com28 Dec 2022

"Provide enough infrastructure and money to carry out surveillance and set up a robust routine surveillance machinery for the country to monitor any and every infectious disease'

The Army Doctor Who Won Hearts In Turkey

The Army Doctor Who Won Hearts In Turkey

Rediff.com8 Mar 2023

Major Beena Tiwari was the only woman in the 99-member medical team at the Indian Army's field hospital in earthquake-hit Turkey.

Oxford University's COVID-19 vaccine test on monkeys shows promise

Oxford University's COVID-19 vaccine test on monkeys shows promise

Rediff.com15 May 2020

The researchers found that after being exposed to high levels of the novel coronavirus, none of the six monkeys that were given the vaccine developed viral pneumonia. Also, there was no sign that the vaccine had made the animals more vulnerable.

India's Omicron count goes up to 6,041

India's Omicron count goes up to 6,041

Rediff.com15 Jan 2022

India registered 2,68,833 new Covid infections in a day taking the tally to 3,68,50,962, which includes 6,041 Omicron variant cases, according to the Union health ministry data on Saturday.

Monkeypox in India: Here's all you need to know about the virus

Monkeypox in India: Here's all you need to know about the virus

Rediff.com25 Jul 2022

Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms similar to those seen in the past in smallpox patients, although it is clinically less severe.

ICMR, Hyderabad co develop potential treatment for COVID-19

ICMR, Hyderabad co develop potential treatment for COVID-19

Rediff.com2 Oct 2020

'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.

Row erupts over Netaji portrait at Rashtrapati Bhavan

Row erupts over Netaji portrait at Rashtrapati Bhavan

Rediff.com25 Jan 2021

A row has erupted over a portrait of Netaji Subhash Chandra Bose which was unveiled by the President at Rashtrapati Bhavan, with people on social media stating that the artwork is that of an actor who played him in a biopic.

Tech giants to assist US govt in combating coronavirus

Tech giants to assist US govt in combating coronavirus

Rediff.com23 Mar 2020

US-based global tech giants, including IBM, Amazon, Google and Microsoft, have partnered with the White House to "unleash the power of American supercomputing resources" for combating the novel coronavirus, President Donald Trump has said. From volunteering to manufacturing masks and ventilators to ramping up production of essential medical supplies and general items, the country's private sector have joined America's war against coronavirus in a big way, Trump said on Sunday, while launching a new public-private consortium organised by the White House, the department of energy and tech company IBM.

COVID-19: India records 12,923 fresh cases, 108 more fatalities

COVID-19: India records 12,923 fresh cases, 108 more fatalities

Rediff.com11 Feb 2021

The number of people who have recuperated from the disease has surged to 1,05,73,372, which translates to a national COVID-19 recovery rate of 97.26 per cent, while the case fatality rate stands at 1.43 per cent.

REVEALED: Why COVID-19 affects men more than women

REVEALED: Why COVID-19 affects men more than women

Rediff.com11 May 2020

Evidence from a large study of several thousand patients shows that men have higher concentrations of angiotensin-converting enzyme 2 in their blood than women. Since ACE2 enables coronavirus to infect healthy cells, this may help to explain why men are more vulnerable to COVID-19 than women.

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

Rediff.com6 Oct 2020

The 'antisera' has been developed by the ICMR in collaboration with a Hyderabad-based bio-pharmaceutical firm. "With Biological E Limited we have developed an horse 'antisera' and we have just got clearance for conducting clinical trials for that," ICMR Director General Dr Balram Bhargava said at press briefing.

Rediff Chat: All your questions on coronavirus answered

Rediff Chat: All your questions on coronavirus answered

Rediff.com29 Mar 2020

Join infectious disease specialist Dr Trupti Gilada on Rediff Chat and have all your queries on coronavirus answered.

New Covid variant: Scientists warn against more mutations

New Covid variant: Scientists warn against more mutations

Rediff.com22 Dec 2020

Over time, as more mutations occur, the vaccine may need to be altered.

How long before the world gets a COVID-19 vaccine?

How long before the world gets a COVID-19 vaccine?

Rediff.com28 Apr 2020

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Active Covid-19 cases in India rise again

Active Covid-19 cases in India rise again

Rediff.com4 Sep 2021

The daily positivity rate was recorded at 2.50 per cent and the weekly positivity rate was 2.63 per cent. It has been below three per cent for the last 71 days.

Conversion row: CBI probe ordered into TN girl's suicide

Conversion row: CBI probe ordered into TN girl's suicide

Rediff.com31 Jan 2022

The Madras high court bench in Madurai on Monday directed transferring the probe into the death by suicide of a 17-year-old girl, allegedly coerced to convert to Christianity, to the Central Bureau of Investigation.

An interface to detect COVID-19 from CT scans, X-Rays

An interface to detect COVID-19 from CT scans, X-Rays

Rediff.com8 May 2020

AI tech that study CT scans and X-Rays are being deployed as part of global efforts to tackle the coronavirus pandemic, according to LPU researchers. The system may enable doctors and medical staff even in remotest villages of the country to get quick results on the COVID-19 status of a patient.

COVID-19 tests may yield false negative if used too early: Study

COVID-19 tests may yield false negative if used too early: Study

Rediff.com11 Jun 2020

Explaining how RT-PCR tests may yield a false negative results, the scientists said, when a swab misses collecting cells infected with the virus, or if virus levels are very low early during the infection, some tests can produce negative results.